throbber
Send Orders for Reprints to reprints@benthamscience.net
`
`Current Drug Delivery, 2013, 10, 667-684
`667
`An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems:
`A Review
`
`Harsha Kathpalia* and Aasavari Gupte
`
`Vivekanand Education Society’s College of Pharmacy, Hashu Advani Memorial Complex, behind Collector Colony,
`Chembur (E), Mumbai - 400 074, India
`
`Abstract: Many pharmaceutical companies are switching their products from tablets to fast dissolving oral thin films
`(OTFs). Films have all the advantages of tablets (precise dosage, easy administration) and those of liquid dosage forms
`(easy swallowing, rapid bioavailability). Statistics have shown that four out of five patients prefer orally disintegrating
`dosage forms over conventional solid oral dosages forms. Pediatric, geriatric, bedridden, emetic patients and those with
`Central Nervous System disorders, have difficulty in swallowing or chewing solid dosage forms. Many of these patients
`are non-compliant in administering solid dosage forms due to fear of choking. OTFs when placed on the tip or the floor of
`the tongue are instantly wet by saliva. As a result, OTFs rapidly hydrate and then disintegrate and/or dissolve to release
`the medication for local and/or systemic absorption. This technology provides a good platform for patent non- infringing
`product development and for increasing the patent life-cycle of the existing products. The application of fast dissolving
`oral thin films is not only limited to buccal fast dissolving system, but also expands to other applications like gastro-
`retentive, sublingual delivery systems. This review highlights the composition including the details of various types of
`polymers both natural and synthetic, the different types of manufacturing techniques, packaging materials and evaluation
`tests for the OTFs.
`Keywords: Film forming polymers, Lycoat, Monoammonium glycyrrhizinate, Oral thin films, Patent non-infringing product
`development, Solvent casting method.
`
`INTRODUCTION
`
`Fast dissolving drug delivery systems were first devel-
`oped in the late 1970s as an alternative to conventional dos-
`age forms. These systems consist of solid dosage forms that
`disintegrate and dissolve quickly in the oral cavity without
`the need of water [1]. Fast dissolving drug delivery systems
`include orally disintegrating tablets (ODTs) and oral thin
`films (OTFs). The Centre for Drug Evaluation and Research
`(CDER) defines ODTs as, “a solid dosage form containing
`medicinal substances which disintegrates rapidly, usually
`within a matter of seconds, when placed upon the tongue”
`[2]. USFDA defines OTFs as, “a thin, flexible, non-friable
`polymeric film strip containing one or more dispersed active
`pharmaceutical ingredients (APIs) which is intended to be placed
`on the tongue for rapid disintegration or dissolution in the
`saliva prior to swallowing for delivery into the gastrointesti-
`nal tract” [3]. OTFs are coming into their own as mainstream
`pharmaceutical products. The first approved prescription
`OTF was Zuplenz (Ondansetron hydrochloride- 4 mg, 8 mg)
`which was approved in 2010. The second approved one was
`Suboxone (Buprenorphine and Naloxone). Statistics have
`shown that four out of five patients prefer orally disintegrat-
`ing dosage forms over conventional solid oral dosages forms
`[4]. These factors, coupled with convenience and compliance
`
`*Address correspondence to this author at the Vivekanand Education Soci-
`ety’s College of Pharmacy, Hashu Advani Memorial Complex, behind Col-
`lector Colony, Chembur (E), Mumbai-400 074, India; Tel: 022-6114 4144,
`022-2554 3600; Fax: 022-2554 3925;
`E-mail: hkathpalia2007@rediffmail.com
`
`advantages, have been (and will continue to) pave the way
`for ODT and OTF drug product growth.
` This review highlights the various types of polymers, the
`different types of packaging materials manufacturing tech-
`niques and evaluation tests for the oral films.
`
`Need for Preparing Fast Dissolving OTFs
`
`Pediatric, geriatric, bedridden, emetic patients and those
`with Central Nervous System disorders, have difficulty in
`swallowing or chewing solid dosage forms. Many of these
`patients are non-compliant in administering solid dosage
`forms due to fear of choking. Even in the case of ODTs, fear
`of choking is associated which can be hazardous. Fast dis-
`solving oral thin film drug delivery system is a better alterna-
`tive to ODTs. OTFs when placed on the tip or the floor of
`the tongue are instantly wet by saliva. As a result, OTFs rap-
`idly hydrate and then disintegrate and/or dissolve to release
`the medication for local and/or systemic absorption. ODTs
`are friable and may break during transport and handling.
`Thus, fast dissolving oral thin film drug delivery systems are
`being developed.
`
`Advantages of OTF
`1). Ease of administration for mentally ill and non-
`compliant patients
`2). Useful in situations where rapid onset of action is re-
`quired such as in motion sickness, allergic attack,
`coughing or asthma
`
`
`
` 1875-5704/13 $58.00+.00
`
`© 2013 Bentham Science Publishers
`
`MONOSOL RX EXHIBIT 2010 page 0001
`
`Plaintiffs' Exhibit
`
`Reckitt Benckiser Pharms. Inc., et al.
`v. Watson Labs., Inc., et al.
`(1:13-cv-01674-RGA)(Con.)
`
`PTX 212
`
`

`
`668 Current Drug Delivery, 2013, Vol. 10, No. 6
`
`Kathpalia and Gupte
`
`3). Has wide range of applications in pharmaceuticals, Rx
`Prescriptions and OTC medications for treating pain,
`cough/cold, gastro-esophageal reflux disease, erectile
`dysfunction, sleep disorders, dietary supplements, etc
`[4].
`4). No water is required for the administration and hence
`suitable during travelling
`5). Some drugs are absorbed from the mouth, pharynx and
`esophagus as the saliva passes down into the stomach,
`enhancing bioavailability of drugs
`6). May offer improved bioavailability for poorly water
`soluble drugs by offering large surface area as the film
`disintegrates and dissolves rapidly
`7). Leaves minimal or no residue in the mouth after admini-
`stration
`8). Has ability to provide advantages of liquid medication in
`the form of solid preparation
`9). Adaptable to existing processing and packaging machinery
`10). Cost-effective
`11). Gives accurate dosing as compared to liquids
`12). Provides good chemical stability
`13). Free of need of measuring, which is an essential draw-
`back in liquids [5].
`14). Offers market expansion and product differentiation
`15). Can be developed and launched within 12-16 months,
`thus provides improved product development life-cycle
`time [4].
`
`Disadvantages of OTF
`1). Dose uniformity is difficult to maintain
`2). Only those active pharmaceutical ingredients (APIs)
`having small dose can be incorporated [6].
`3). Research has proven that concentration level of active
`pharmaceutical ingredient (API) can be improved up to
`50% w/w. Novartis Consumer Health's Gas-X® thin
`strip has 62.5 mg of Simethicone per strip [4].
`4). Require expensive packaging
`5). Since OTFs dissolve quickly, dose termination is impos-
`sible
`6). OTFs is not official in any pharmacopoeia
`
`FORMULATION OF FAST DISSOLVING OTFs
`
`Formulation includes consideration regarding mechanical
`properties, taste masking, fast dissolving, physical appear-
`ance, mouth feel. Fast dissolving oral thin films are generally
`with an area of 5-20 cm2. APIs can be incorporated upto 50
`mg [7]. From the regulatory point of view, all the excipients
`used should be generally regarded as safe (GRAS) listed and
`should be used as per Inactive Ingredients Limit (IIG limit).
`Various components of fast dissolving oral thin films are
`shown in (Table 1).
`
`Table 1. Composition of Fast Dissolving Oral Thin Films [8].
`
`Components
`
`Active pharmaceutical ingredients
`
`Film forming polymers
`
`Plasticizers
`
`Surfactants
`
`Sweetening agents
`
`Saliva stimulating agents
`
`Superdisintegrants
`
`Coloring agents
`
`Flavoring agents
`
`% w/w
`
`5-50
`
`Upto45
`
`0-20
`
`q. s.
`
`3-6
`
`2-6
`
`Upto 8
`
`Upto 1
`
`Upto 10
`
`Active Pharmaceutical Ingredients (APIs)
`
`Since the size of the thin films has to be small enough to
`be conveniently placed on the tongue, those active pharma-
`ceutical ingredients with high dose are not suitable candi-
`dates for incorporation into fast dissolving oral thin films [9].
`
`Ideal Characteristics of APIs to be Incorporated into Fast
`Dissolving OTFs
`1). Low dose
`2). Palatability
`3). Small molecular weight
`4). Solubility and stability in saliva
`
`Some of the suitable candidates for incorporation into
`thin film formulation are given in (Table 2).
` Water soluble APIs exist in the dissolved state or as solid
`solution and there is no problem of uniformity of distribu-
`tion. But water insoluble APIs have to be homogenously
`distributed so as to have an acceptable drug content uniform-
`ity. Water insoluble APIs can also be added as milled, mi-
`cronized or in the form of nanocrystals or microcapsules [10]
`in order to maintain smooth texture of the film and also for
`fast dissolution.
`Lou et al. formulated Chlorpheniramine maleate mi-
`•
`croparticles by encapsulating Chlorpheniramine maleate
`into Eudragit EPO by spray drying of water-in-oil emul-
`sion method. The optimized microparticles were incor-
`porated into OTF with satisfactory weight and drug con-
`tent uniformity and acceptable physical strength. OTFs
`disintegrated immediately (in less than 40 seconds) in
`simulated saliva solutions [11].
`Sievens-Figueroa et al. formulated OTFs of hy-
`droxypropyl methyl cellulose (HPMC) by incorporating
`API in the form of nanosuspension. They transformed
`nanosuspension produced from wet stirred media mill-
`ing (WSMM) into polymer films containing drug loaded
`nanoparticles by mixing with HPMC E15 LV solution
`containing glycerin followed by film casting and drying [12].
`
`•
`
`MONOSOL RX EXHIBIT 2010 page 0002
`
`

`
`An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems
`
`Current Drug Delivery, 2013, Vol. 10, No. 6 669
`
`Table 2. Suitable Candidates for Incorporation into Thin
`Film Formulation.
`
`Active Pharmaceutical
`Ingredients
`
`Category
`
`Dose (mg)
`
`Levocetrizine
`Loratadine
`
`Ketorolac
`Indomethacin
`Valdecoxib
`Piroxicam
`
`Zolmitriptan
`Sumatriptan succinate
`
`Mirtazapine
`
`Buspirone
`
`Carvedilol
`
`Glipizide
`
`Galantamine
`Donepezil
`
`Anti-histaminic
`
`NSAIDs
`
`Anti-migraine
`
`Anti-depressant
`
`Anxiolytic
`
` -blocker
`
`Anti-diabetic
`
`Anti-Alzheimer
`
`Nitroglycerine derivatives
`
`Vasodilator
`
`Benzocaine
`
`
`
`Buprenorphine/Naloxone
`
`Opioid analgesic
`
`Ondansetron
`
`Antacid
`
`5, 10
`10
`
`10
`25
`10, 20
`10, 20
`
`2.5, 5
`35, 70
`
`15, 30, 45
`
`5, 15, 30
`
`3.125, 6.25, 12.5,
`25
`
`2.5, 5
`
`4, 8, 12
`5, 10
`
`0.3, 0.6
`
`
`
`2.5-10
`
`10
`
`d-Amphetamine
`
`Anti-inflammatory
`
`12.5, 25
`
`Clonazepam
`
`Ondansetron
`
`Loperamide
`
`Buprenorphine
`Naloxone
`
`d-Amphetamine
`
`Anti-tussive
`
`Anti-emetic
`
`Anti-diarrheal
`
`Treatment of opioid
`addiction
`
`Treatment attention
`deficit hyperactive
`disorder
`
`15, 30
`
`8-24
`
`2
`
`2, 4, 16, 24
`
`0.5, 1, 4, 6
`
`10, 20
`
`Clonazepam
`
`Anti-epileptic
`
`0.5, 1, 1.5
`
` As the thin OTF formulation is to be placed on tongue,
`those drugs having bitter and unpleasant taste may cause
`vomiting sensation and may be inacceptable by the patient.
`Hence, various taste masking technologies for bitter drugs
`like microencapsulation, inclusion complexation with cyclo-
`dextrins, complexation with ion-exchange resins are being
`practiced.
`Prednisolone drug particles were masked by ethyl cellu-
`•
`lose and Eudragit E by emulsion solvent evaporation
`technique and incorporated into ODT. This technique
`can be further extended to OTF formulation [13].
`
`•
`
`•
`
`•
`
`In fast dissolving OTF formulation for treating erectile
`dysfunction, hydroxylpropyl-beta-cyclodextrin (HP- -CD)
`was used as a taste masking agent [14].
`Preis et al. developed taste masked orodispersible film
`containing Dimenhydrinate using HP- -CD as a taste
`masking agent [15].
`Ion exchange resin like Amberlite IRP 69 was used to
`formulate taste masked fast dissolving orally consum-
`able films of Dextromethorphan [16].
`
`Film Forming Polymers
`
`Since the film formulation rapidly disintegrates and dis-
`solves in oral cavity, the film forming polymers used must
`be water soluble. The polymers can be used alone or in com-
`bination with others in order to obtain the desired film which
`should be tough enough so that there won't be any damage
`while handling or during transportation and at the same time
`showing fast dissolution in the mouth. The robustness of the
`film depends on the type and amount of polymer used in the
`formulation. The disintegration time of the polymers is in-
`creased by increasing the molecular weight of polymer film
`bases [17]. Since polymers are the major components of the
`film formulation along with the APIs, their proportion re-
`lated to each other is governed by 2 factors:
`a). Minimum % w/w concentration of polymer required to
`form matrix which incorporates APIs and other excipients
`with desirable mechanical and viscoelastic properties.
`b). % w/v concentration of polymer in solution to be casted
`as film which is governed by the desired viscosity. Vis-
`cosity should be optimum enough to prevent suspended
`solids from settling and to form a smooth spreadable
`film [18].
`
`Ideal Properties of Polymers
`1). Non-toxic
`2). Non-irritant
`3). Bland
`4). Good mouth feel
`5). Should be stable for long period
`6). Should not alter properties of the active pharmaceutical
`ingredient or other excipients of the formulation
`Inexpensive
`7).
`8). Should have good wettability and spreadability
`9). Should not retard the disintegration time of the film
`10). Should have optimum peel strength and tensile strength
`
`NATURAL POLYMERS
`Gum Polysaccharides
` Gum polysaccharides like gum arabic, -carageenan, and
`sodium alginate are some of the potential polymers for film
`formation. They can be used in combination with others so
`as to provide primary film structure and rapid dissolving
`characteristics. Some examples are shown in (Table 3).
`
`MONOSOL RX EXHIBIT 2010 page 0003
`
`

`
`670 Current Drug Delivery, 2013, Vol. 10, No. 6
`
`Kathpalia and Gupte
`
`residues. It is a fungal exopolysaccharide produced from
`starch by black yeast Aureobasidium pullulan [24]. Bender
`and Wallenfels discovered the enzyme pullulanase, which
`specifically hydrolyzes (16) linkage in pullulan and con-
`verts the polysaccharide to maltotriose. Catley and co-
`workers established the occurrence of a minor percentage of
`randomly distributed maltotetraose subunits in pullulan [25].
`The regular occurrence of (16) linkage in pullulan inter-
`rupts a linear amylase chain. This unique pattern of linkage
`is responsible for the structural flexibility of pullulan, result-
`ing in distinct film forming characteristics [26]. Pullulan PI-
`20 grade is the deionised form of pullulan having an average
`molecular weight of 2,00,000 daltons and possess excellent
`film forming properties. Pullulan is used in range 0.3-15%
`w/w [27].
`
`Advantages
`a). Addition of these can improve can improve dissolution
`of films in mouth
`b). Reduces tensile strength only to a minimal extent
`
`Table 3. Film Composition and the Resulting Dissolution
`Time [19].
`
`Film Composition
`
`Dissolution Time
`(Seconds)
`
`Gum arabic (1.25%) along with sodium alginate
`(2.5%) and low viscosity carboxy methyl cellulose
`(1.25%) and water
`
` -carageenan (1.25%) along with sodium alginate
`(2.5%) and low viscosity carboxy methyl cellulose
`(1.25%) and water
`
`Polydextrose (1.25%) along with sodium alginate
`(2.5%) and low viscosity carboxy methyl cellulose
`(1.25%) and water
`
`20
`
`28
`
`12.60
`
`Gelatin
` Gelatin consists of a mixture of purified protein fractions
`obtained either by partial acid hydrolysis which is called as
`type A gelatin or by partial alkaline hydrolysis which is
`called as type B gelatin of animal collagen. Gelatin is pre-
`pared by the thermal denaturation of collagen isolated from
`animal skin, bones and fish skins [20]. It is readily soluble in
`water above 40º C and it forms viscous solution of randomly
`coiled polypeptide chains. Mammalian gelatins have better
`physical properties and thermostability than most of the fish
`gelatins due to their higher amino acid content. The proper-
`ties and film forming ability of gelatin is directly related to
`the molecular weight of the gelatin, i.e., the higher the aver-
`age molecular weight, better the quality of the film. The mo-
`lecular weight distribution depends mainly on the degree of
`cross-linking of collagen fibers and the extraction procedure
`used. Gelatin films could be formed from 20-30% gelatin,
`10-30% plasticizer (glycerin or sorbitol) and 40-70% water
`followed by drying the gelatin gel [21].
`
`Advantages of Gelatin Films
`a). Dissolve rapidly
`b). Films are excellent carriers for flavors
`c). Films produce a smooth mouth feel [22].
`• Ghorwade et al. formulated Montelukast sodium fast
`dissolving films using gelatin as a film base (3.54%
`w/w). It was observed that films had desired tensile
`strength and optimum in vitro dissolution time [23].
`
`Pullulan
`
`Pullulan is a biopolymer. It is water soluble, neutral lin-
`ear polysaccharide consisting of (16) linked maltotriose
`
`d).
`
`e).
`f).
`
`Advantages of Pullulan
`a).
`It is non-hygroscopic
`b).
`It is impermeable to oxygen Impermeability of pullulan
`films to oxygen is suitable for protection of readily oxi-
`dized fats and vitamins in food. Pullulan films have 300
`times stronger oxygen barrier than HPMC films and 9
`times stronger oxygen barrier than gelatin films of the
`same thickness [28].
`c). No branching in structure in contrast to gum arabic,
`forming much stronger films [29].
`It is easily soluble in cold and hot water to make clear
`and viscous solution
`It also has high adhesion and film forming abilities
`It is a nonionic polysaccharide and is bio-compatible,
`biodegradable
`It is non-toxic, non-immunogenic, non-mutagenic and
`non-carcinogenic [30].
`h). Pullulan films are thermally stable and possess anti-
`static and elastic properties
`i). Pullulan films can be developed into compression molding
`j). Pullulan films are highly water soluble, colorless, taste-
`less, odorless, transparent and flexible
`• Mishra et al. formulated rapidly dissolving films of
`Cetirizine hydrochloride using pullulan (15% w/w) as a
`film forming agent. They found that the amount of plas-
`ticizer was critical for film formation and separation
`properties. Acceptable mechanical properties and in vi-
`tro disintegration time were obtained [31].
`• Orally disintegrating film formulation of Nicotine is
`shown in (Table 4).
`
`g).
`
`Starch
`
`Starch is the major carbohydrate reserve in plant tubers
`and seed endosperm where it is found as granules. Each
`granule contains millions of amylopectin molecules accom-
`panied by smaller amylase molecules. Amylose is responsi-
`ble for the film forming capacity of starch [33].
`
`MONOSOL RX EXHIBIT 2010 page 0004
`
`

`
`An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems
`
`Current Drug Delivery, 2013, Vol. 10, No. 6 671
`
`Table 4. Nicotine Orally Disintegrating Film.
`
`Ingredients
`
`Nicotine base
`
`Alginic acid
`
`Pullulan
`
`Purified water
`
`Sucralose
`
`Solutol H15
`
`Sucrose fatty acid esters D-1811
`
`Alcohol
`
`Glycerin
`
`Triethyl citrate
`
`Tween 80
`
`Span 80
`
`Peppermint oil
`
`Menthol
`
`FD & C Yellow #6
`
`TOTAL
`
`Amount per Film (mg)
`
`1.00
`
`0.50
`
`29.48
`
`0.0038
`
`0.48
`
`1.00
`
`1.00
`
`0.00
`
`3.20
`
`2.00
`
`0.60
`
`0.10
`
`0.40
`
`0.20
`
`0.04
`
`40.00
`
` In above formulation, hydroalchoholic vehicle was used [32].
`
`Advantages of Starch
`a). Starch films are biodegradable
`b). Starch films are transparent or translucent
`c). Starch films are flavorless, tasteless and colorless [34].
`
`Disadvantages of Starch
`a). Starch films have poor mechanical strength
`b). Film forming conditions have an effect on crystallinity
`of the starch films and their properties
`Films of high-amylose corn starch or potato starch were
`
`more stable during aging, lost little of their elongation and
`had slight or no increase in tensile strength [35]. Films from
`cassava starch had good flexibility and low water permeability,
`indicating the potential application as edible film former [36].
` Modified starch, due to its low cost, is being widely used
`in combination with pullulan.
`
`Lycoat
` Lycoat is a novel granular hydroxypropyl starch polymer
`obtained from pea starch that has been designed especially
`for fast dissolving OTFs. It is manufactured by Roquette
`Pharma.
`
`Advantages of Lycoat
`a). Lycoat disperses easily in cold water without formation
`of lumps
`
`•
`
`b).
`
`It can be used alone as film forming polymer to formu-
`late fast dissolving OTFs with excellent functionality
`without the need of additional film forming agent
`[37].
`c).
`It is neutral in taste
`It forms films without the use of organic solvents
`d).
`e). APIs can be loaded in crystalline form or they can be
`solubilized in an organic solvent
`Popescu et al. formulated oral disintegrating films of
`Benzocaine using Lycoat RS 720 as a film forming
`polymer. They concluded that Lycoat RS 720 alone was
`capable of producing orally disintegrating films. It also
`offered dose homogeneity and fast dissolution [38].
`• Doaa et al. formulated Tianeptine sodium orodispersible
`films using Lycoat NG 73 as a film forming polymer.
`They concluded that the films made up of Lycoat NG 73
`showed the highest dissolution rate, suitable in vitro dis-
`integration time and satisfactory physico-mechanical
`properties as compared to those made up of other poly-
`mers [39].
`
`Maltodextrin
` Maltodextrin is a non- sweet nutritive saccharide poly-
`mer. It is produced by partial hydrolysis of starch. Maltodex-
`trin consists of D-glucose units connected in chains of vari-
`able length. The glucose units are primarily linked with
`(14) glycosidic bond. Maltodextrin is typically composed
`of a mixture of chains that vary from 3-19 glucose units [40].
`Maltodextrins are classified by DE (dextrose equivalent) and
`have DE between 3-20. Higher the DE value, shorter the
`glucose chains, higher the sweetness and higher the solubil-
`ity [18]. Maltodextrin is used in the range of 2-10% w/w
`[41].
`Cilurzo et al. formulated Nicotine fast dissolving films
`•
`made of maltodextrin. They found that on decreasing the
`DE value of maltodextrin, the tenacity of the film im-
`proved [42].
`
`SYNTHETIC POLYMERS
`Hydroxypropylmethyl Cellulose (HPMC)
` HPMC or hypromellose is partly O-methylated and O-(2-
`hydroxypropylated) cellulose [43]. Depending upon the vis-
`cosity grades, concentrations of 2-20% w/w are used for film
`forming solutions [44]. Lower grades of HPMC like HPMC
`E3, HPMC E5and HPMC E15 are particularly used for film
`formation because of their low viscosity [45]. Lower grades
`are used with aqueous solvent [38]. Additives are incorpo-
`rated to improve specific properties of films. Several studies
`have been carried out to investigate the influence of additives
`on physico-chemical properties of HPMC films. Lipids such
`as waxes, triglycerides (tristearin), fatty acids (stearic acid,
`palmitic acid) result in decreased water affinity and moisture
`transfer due to their high hydrophobic properties [23].
`
`Advantages of HPMC
`a).
`It has good film forming properties and excellent ac-
`ceptability
`
`MONOSOL RX EXHIBIT 2010 page 0005
`
`

`
`672 Current Drug Delivery, 2013, Vol. 10, No. 6
`
`Kathpalia and Gupte
`
`•
`
`b). HPMC forms transparent, tough and flexible films in
`aqueous solutions [43].
`• Nishimura et al. formulated Prochlorperazine oral disin-
`tegrating film using of HPMC (7.4% w/w) in combina-
`tion with low substituted HPC (1.3% w/w). Films
`showed excellent stability and desired dissolution profile
`[45].
`Shimoda et al. prepared fast dissolving OTFs containing
`Dexamethasone using HPMC (7.4% w/w) in combina-
`tion with low substituted HPC (1.3% w/w). 90% of
`Dexamethasone was found to be dissolved within 5
`minutes [46].
`Raju S et al. formulated and evaluated flash release oral
`films of Metoclopramide hydrochloride. The formula-
`tion released 99.40% of drug within 30 seconds [47].
`Joshi et al. formulated and evaluated mouth dissolving
`films of Domperidone. The film was prepared by sol-
`vent casting technique utilizing HPMC E15 as film
`forming agent and PEG 400 as plasticizer. The film con-
`taining HPMC E15 (500 mg) showed greater dissolution
`(more than 75% within 15 minutes), satisfactory in vitro
`disintegration time (45 seconds) and suitable physico-
`mechanical properties [48].
`• Orally disintegrating film formulation of Diclofenac is
`shown in (Table 5).
`
`•
`
`•
`
`Table 5. Diclofenac Orally Disintegrating Film [49].
`
`Ingredients
`
`Amount per Film (mg)
`
`Diclofenac free acid
`
`Methocel E5 (HPMC E5)
`
`Methocel E50 (HPMC E50)
`
`Glycerol
`
` -Tocopherol
`
`Spearmint flavor 501495 T
`
`Masking flavor 501483 T
`
`Sodium chloride
`
`Levomenthol
`
`Acesulfame-K
`
`Water
`
`TOTAL
`
`11.08
`
`3.20
`
`4.80
`
`0.70
`
`0.0064
`
`0.70
`
`2.75
`
`0.75
`
`1.50
`
`0.75
`
`37.00
`
`26.23
`
`Polyvinyl Alcohol (PVA)
`
`Poly (vinyl alcohol) (PVA), a polyhydroxy polymer, is
`the synthetic, water-soluble polymer which is produced
`commercially by the hydrolysis of poly (vinyl acetate)
`(PVAc). To improve its deformability, PVA is usually plas-
`ticized by low molecular compounds mostly containing polar
`groups, which associate with hydroxyl groups of PVA chain
`(with or without water assistance) developing hydrogen bonds.
`
`Advantages of PVA
`a). PVA has excellent film forming and emulsifying properties
`b).
`It is resistant to oil and grease
`c). PVA is odorless and nontoxic
`d). PVA has high oxygen and aroma barrier properties
`e). PVA has high enough tensile strength and satisfactory
`flexibility
`f). High biodegradability [50].
`• Kulkarni et al. formulated mouth dissolving films con-
`taining Rofecoxib where, PVA (4%w/w) was used to as
`film forming polymer. They found that, with increasing
`the concentration of PVA, elasticity of the film in-
`creased and release of the drug occurred within 1 minute
`[51].
` Ondansetron RapidFilm formulation is shown in (Table 6).
`
`Table 6. Ondansetron RapidFilm Formulation.
`
`Ingredients
`
`Ondansetron base
`
`Mowiol (Poly vinyl alcohol)
`
`Polyethylene glycol
`
`Glycerol anhydrous
`
`Rice starch
`
`Acesulfame-K
`
`Titanium dioxide
`
`Menthol
`
`Polysorbate
`
`TOTAL
`
`Amount per film (mg)
`
`8.00
`
`22.00
`
`6.00
`
`2.00
`
`10.00
`
`0.20
`
`0.30
`
`1.00
`
`1.00
`
`50.50
`
` Dissolution profiles of Ondansetron film coated tablet,
`oral dissolving tablet (Zofran 8 mg and 4 mg) and RapidFilm
`(8 mg and 4 mg) were compared. Dissolution studies were
`carried out in USP apparatus Type I (paddle), using 900 ml
`of 0.1 N HCl buffered water at pH 1.0 at 100 rpm and 37o C.
`The results of the dissolution study can be summarized as
`follows:
`• Ondansetron film coated tablet showed 0.8% drug re-
`lease in one minute while at the time point of 10 min-
`utes; it showed 103.3% drug release.
`• Orally dissolving tablet (8 mg) showed 100.30% drug
`release in one minute while RapidFilm (8 mg) showed
`97.10% drug release in one minute. At the time point of
`10 minutes, both the formulations showed 100.80% drug
`release.
`• Orally dissolving tablet (4 mg) showed 102.30% drug
`release in one minute while RapidFilm (4 mg) showed
`71.80% drug release in one minute. At the time point of
`10 minutes, orally dissolving tablet (4 mg) showed
`
`MONOSOL RX EXHIBIT 2010 page 0006
`
`

`
`An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems
`
`Current Drug Delivery, 2013, Vol. 10, No. 6 673
`
`101.80% drug release in one minute while RapidFilm
`(4 mg) showed 105.20% drug release.
`From the above data, it can be concluded that though the
`
`drug release from orally dissolving tablet is faster than
`RapidFilm initially, at the time point of 10 minutes, drug
`release from both the formulations is comparable and both
`are better formulations as compared to Ondansetron film
`coated tablet [52].
`
`Polyethylene Oxide (PEO)
`
`Polyethylene oxide is a synthetic polyether. It is available
`in a wide range of molecular weights. Usually 3-5% w/w
`solution is used for film formation [53].
`
`Advantages of PEO
`a). PEO has a high melting point
`b).
`It has good structural integrity
`c).
`It has low glass transition temperature
`d).
`It has low toxicity and biocompatibility
`e).
`It is highly hydrophilic with good film forming capacity
`[18].
`Sumitha et al. formulated rapid disintegrating films of
`Ondansetron using PEO N10 and HPMC E15. It was
`observed that incorporation of PEO helped in faster dis-
`integration and provided good elegance to the film [54].
`Representative formulation of Donepezil hydrochloride
`orally disintegrating film is shown in (Table 7).
`
`•
`
`•
`
`Donepezil
`of
`Formulation
`Table 7. Representative
`Hydrochloride Orally Disintegrating Film [52].
`
`Ingredients
`
`Amount per Film (mg)
`
`Donepezil hydrochloride
`
`Polyethyleneoxide
`
`Tween 80
`
`Glycerol anhydrous
`
`Citric acid anhydrous
`
`Titanium dioxide
`
`Acesulfame-K
`
`Anise flavor
`
`Peppermint flavor
`
`TOTAL
`
`10.00
`
`50.00
`
`1.00
`
`12.00
`
`1.00
`
`0.50
`
`1.50
`
`1.65
`
`3.84
`
`81.49
`
`Polyvinyl Pyrrolidone (PVP)
`
`Soluble polyvinyl pyrrolidoneis synthesized by radical
`polymerization of N-vinyl pyrrolidone in 2-propanol. The
`soluble PVP products of pharmaceutical quality are
`designated as Povidone in the USP. Soluble PVP products
`are marketed under bran name Kollidon®. PVP range
`
`comprises of products of different K-values. The K-value is
`associated with themean molecular weight. Itis included as
`part of the trade name and is calculated from the relative
`viscosity in water. Different grades of PVP and their mean
`molecular weight is shown in (Table 8).
`
`Table 8. Different Grades of PVP and their Mean Molecular
`Weight.
`
`Grades of PVP
`
`Mean Molecular Weight
`
`Povidone K 12
`
`Povidone K 25
`
`Povidone K 30
`
`Povidone K 90
`
`2000-3000
`
`28000-34000
`
`44000-54000
`
`1000000-1500000
`
`Advantages of PVP
`a). PVP is readily soluble in water and most other solvents
`b). PVP has a very good film forming capacity
`c).
`It has ability of to form a water-soluble complexes with
`insoluble APIs which can improve their release rate and
`solubility
`It is non-toxic and chemically inert
`d).
`It is temperature resistant, pH-stable and colorless [55].
`e).
`f). Films are clear, glossy and hard [56].
`• Gaisford et al. formulated PVP films containing
`Indomathacin to evaluate the potential of isothermal
`calorimetry to monitor and characterize crystallization in
`drug-loaded fast dissolving oral films [57].
`Cheun et al. formulated mouth dissolving film of Car-
`bamazepine using PVP K30 as film forming polymer.
`They found that crystallization of Carbamazepine oc-
`curred due to hygroscopicity of PVP [58].
`• Ali et al. formulated Diphenhydramine and Ibuprofen
`strips with Kollidon K-90. Diphenhydramine films
`showed disintegration time of 50 seconds while that of
`Ibuprofen strips was 5-6 times higher [59].
` Major manufacturing companies of the polymers are
`shown in (Table 9).
`
`•
`
`Plasticizers
`
`Plasticizers aid in improving the flexibility and reduce
`the brittleness of the film by reducing the glass transition
`temperature of the polymer. Plasticizers also improve the
`tensile strength and reduce brittleness. The plasticizer should
`be compatible with the polymer and the solvent used. Plasti-
`cizers also enhance the tensile strength of the polymers [60,
`61]. Glycerol, propylene glycol, low molecular weight poly-
`ethylene glycols, citrate derivatives such as tributyl citrate,
`triethyl citrate, triacetin and castor oil are some of the com-
`monly used plasticizers [62-68]. Inappropriate or extensive
`use of plasticizer can cause film cracking; splitting and peel-
`
`MONOSOL RX EXHIBIT 2010 page 0007
`
`

`
`674 Current Drug Delivery, 2013, Vol. 10, No. 6
`
`Kathpalia and Gupte
`
`ing of the film. Some plasticizers also affect the absorption
`rate of the drug [51]. The plasticizer should impart the per-
`manent flexibility to the film. Plasticization takes place by
`two mechanisms: internal plasticization which involves
`chemical interaction of molecular groups of the polymer
`itself and external plasticization where, a physically active
`plasticizer is externally added. External plasticization does
`not involve chemical interactions in the product and hence, it
`is the preferred mechanism of plasticization [68]. Cellulosic
`hydrophilic polymers are easily plasticized with hydroxyl
`containing plasticizers like polyethylene glycol, propylene
`glycol, glycerol and polyols. In contrast, less hydrophilic
`cellulosic polymers are plasticized wit

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket